Checkmab S.r.l.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy) (NCT06842407) | Checkmab S.r.l. | 2023-04-01 |
Track Checkmab S.r.l. automatically
Every clearance here is in the API, with alerts when new ones post.